N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease
Yıl: 2018 Cilt: 25 Sayı: 1 Sayfa Aralığı: 145 - 147 Metin Dili: İngilizce DOI: 10.5455/jtomc.2018.01.07 İndeks Tarihi: 04-10-2018
N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease
Öz: Aim: Instent restenosis is associated with a poor outcomes in coronary artery disease patients. There are many factors and mechanisms that contribute to the development of IRS. Some of clinical trials have been shown that N-Terminal –pro Brain Nnatriuretic Peptide has an important prognostic value in coronary artery disease. we aimed to evaluate the relationship between stent restenosis and N-Terminal–pro Brain Nnatriuretic Peptide in patients of stable coronary artery disease undergo percutaneous coronary intervention.Material and Methods: 411 patients with stent implantation due to stable coronary artery disease were evaluated and eighty patients underwent re-coronary angiography because of recurrent angına. NT-proBNP measured before coronary intervention. The patients were divided into two groups of instent restenosis developed and undeveloped.Results: In the multivariate regression analysis; Age (OR = 1.067; 95% CI 1.002-1136, P = 0.042) and NT-proBNP (OR = 1.023, 95% CI 1.008-1.038.p = 0.002). ) have been shown that they were independent predictors of IRS. The optimal threshold NT-pro BNP value for predicting IRS was >111, with a 56.5% sensitivity and 92% specificity (area under the curve [AUC]: 0.749, 95% CI: 0.639-0.840, P <0.001).Conclusion: Measurement of NT-proBNP ın stable coronary artery disease patients used to predict IRS; may help physicians to estimate the presence of IRS.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- Taniwaki M, Stefanini GG, Silber S, Richardt G, Vranckx P, Serruys PW, et al. 4-year clinical outcomes and predictors of repeat revascularization in patients treated with new-generation drug-eluting stents: a report from the RESOLUTE all-comers trial (a randomized comparisonof a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary ıntervention). J Am Coll Cardiol 2014;63(16):1617-25.
- Sir JJ, Chung WY, Hwang SJ, Kang HJ, Cho YS, Koo BK, et al. N-Terminal Pro-B-type natriuretic peptide as a predictor of repeat coronary revascularization. Int J Cardiol 2008;126(3):322-32.
- Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD. N-Terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110(20):3206-12.
- Marumoto K, Hamada M, Hiwada K. Increased Secretion of Atrial and Brain Natriuretic Peptides During Acute Myocardial Ischaemia Induced by Dynamic Exercise In Patient With Angina Pectoris. Clin Sci (Lond) 1995;88(5):551-6.
- Wei P, Wang HB, Fu Q, Bai J, Zhu Q. Levels of BNP and stress blood glucose in acute coronary syndrome patients and their relationships with the severity of coronary artery lesion. Cell Biochem Biophys 2014 ;68(3):535-9.
- Lee S, Yoon CH, Oh IY, Suh JW, Cho YS, Cho GY, et al. Angiographic patterns of restenosis with 2nd generation drug-eluting stent:comparative analysis from a 10-year single-center experience. Int Heart J 2015;56(1):6-12.
- Hong SN, Ahn Y, Yoon NS, Lee KH, Kim YS, Hwang SH, et al. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict ın-stent restenosis in patient with preserved left ventricular function and normal troponin I evels. Am J Cardiol 2007;99(8):1051-4.
- Sabatina MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M et al. Acute Changes In Circulating Natriuretic Peptide Levels In Relation to Myocardial Ischemia. J Am Coll Cardiol 2004;44(10):1988-95.
- Oremus M, Raina PS, Santaguida P, Balion CM, McQueen MJ, McKelvie R, et al. A Systemic review of BNP as A predictor of prognosis In persons with coronary artery disease. Clin Biochem 2008;41(4-5)260-5.
- Batyraliev T, Avşar Ö. Stent İçi Restenoz ve İlaçlarla Kaplı Stentler. Türk Girişimsel Kardiyoloji Dergisi 2007;11:163-9.
- Barlis P, Horrigan MC, Chan RK, Ajani AE, Proimos G, Schumer W, et al. What is the best contemporary treatment for ın-stent restenosis? Cardiovascular Revasc Med 2005;6(4)179-81.
- Yavuz F, Ozer O, Ercan S, Yuce M, Davutoglu V, Alici H, et al. Relationship between coronary in-stent restenosis and plasma urotensin II level. Minerva Cardioangiol 2014;62(3):297-303.
- Libby P, Ridker PM, Hansson GK. Leducq Transatlantic Network on Atherothrombosis. Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 2009;54(23):2129-38.
- Bonow RO, Bacharach SL, Green MV, Kent KM, Rosing DR, Lipson LC, el al. Impaired left ventricular diastolic filling in patients with coronary arterydisease : Assessment with radionuclide angiography. Circulation 1981;64(2):315-23.
| APA | BAYRAMOĞLU A (2018). N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. , 145 - 147. 10.5455/jtomc.2018.01.07 |
| Chicago | BAYRAMOĞLU Adil N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. (2018): 145 - 147. 10.5455/jtomc.2018.01.07 |
| MLA | BAYRAMOĞLU Adil N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. , 2018, ss.145 - 147. 10.5455/jtomc.2018.01.07 |
| AMA | BAYRAMOĞLU A N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. . 2018; 145 - 147. 10.5455/jtomc.2018.01.07 |
| Vancouver | BAYRAMOĞLU A N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. . 2018; 145 - 147. 10.5455/jtomc.2018.01.07 |
| IEEE | BAYRAMOĞLU A "N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease." , ss.145 - 147, 2018. 10.5455/jtomc.2018.01.07 |
| ISNAD | BAYRAMOĞLU, Adil. "N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease". (2018), 145-147. https://doi.org/10.5455/jtomc.2018.01.07 |
| APA | BAYRAMOĞLU A (2018). N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, 25(1), 145 - 147. 10.5455/jtomc.2018.01.07 |
| Chicago | BAYRAMOĞLU Adil N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi 25, no.1 (2018): 145 - 147. 10.5455/jtomc.2018.01.07 |
| MLA | BAYRAMOĞLU Adil N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, vol.25, no.1, 2018, ss.145 - 147. 10.5455/jtomc.2018.01.07 |
| AMA | BAYRAMOĞLU A N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi. 2018; 25(1): 145 - 147. 10.5455/jtomc.2018.01.07 |
| Vancouver | BAYRAMOĞLU A N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi. 2018; 25(1): 145 - 147. 10.5455/jtomc.2018.01.07 |
| IEEE | BAYRAMOĞLU A "N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease." İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, 25, ss.145 - 147, 2018. 10.5455/jtomc.2018.01.07 |
| ISNAD | BAYRAMOĞLU, Adil. "N-terminal pro-brain natriuretic peptide predicts instent restenosis in patients with stable coronary artery disease". İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi 25/1 (2018), 145-147. https://doi.org/10.5455/jtomc.2018.01.07 |
